cgmp guidelines Options
No. 21 CFR 211.113(a) demands suitable published processes for being proven and followed through manufacturing to stop objectionable microorganisms in drug products not necessary to be sterile. In addition, the second paragraph of USP General Chapter Antimicrobial Performance Testing reads: Antimicrobial preservatives shouldn't be utilized